397 related articles for article (PubMed ID: 19335435)
21. A study to determine the effect of tacrolimus on ceramide levels in the stratum corneum of patients with atopic dermatitis.
Paslin D; Wertz P
Int J Dermatol; 2006 Apr; 45(4):352-6. PubMed ID: 16650156
[TBL] [Abstract][Full Text] [Related]
22. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A;
Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898
[TBL] [Abstract][Full Text] [Related]
23. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Atzori F; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
[TBL] [Abstract][Full Text] [Related]
24. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.
Patel RR; Vander Straten MR; Korman NJ
Arch Dermatol; 2003 Sep; 139(9):1184-6. PubMed ID: 12975161
[TBL] [Abstract][Full Text] [Related]
25. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
Negi O; Tominaga M; Tengara S; Kamo A; Taneda K; Suga Y; Ogawa H; Takamori K
J Dermatol Sci; 2012 Apr; 66(1):37-43. PubMed ID: 22381253
[TBL] [Abstract][Full Text] [Related]
26. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
[TBL] [Abstract][Full Text] [Related]
27. Expression of adhesion molecules in atopic dermatitis is reduced by tacrolimus, but not by hydrocortisone butyrate: a randomized immunohistochemical study.
Caproni M; Torchia D; Antiga E; Volpi W; Fabbri P
Clin Exp Dermatol; 2006 Nov; 31(6):813-7. PubMed ID: 17040264
[TBL] [Abstract][Full Text] [Related]
28. The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis.
Reitamo S; Mandelin J; Rubins A; Remitz A; Mäkelä M; Cirule K; Rubins S; Zigure S; Ho V; Dickinson J; Undre N
Int J Dermatol; 2009 Apr; 48(4):348-55. PubMed ID: 19335418
[TBL] [Abstract][Full Text] [Related]
29. Tacrolimus reduces staphylococcal colonization on the skin in Korean atopic dermatitis patients.
Park CW; Lee BH; Lee CH
Drugs Exp Clin Res; 2005; 31(2):77-87. PubMed ID: 15929609
[TBL] [Abstract][Full Text] [Related]
30. Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis.
Wollenberg A; Sidhu MK; Odeyemi I; Dorsch B; Koehne-Volland R; Schaff M; Ehlken B; Berger K
Br J Dermatol; 2008 Dec; 159(6):1322-30. PubMed ID: 18782316
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
Bieber T; Vick K; Fölster-Holst R; Belloni-Fortina A; Städtler G; Worm M; Arcangeli F
Allergy; 2007 Feb; 62(2):184-9. PubMed ID: 17298428
[TBL] [Abstract][Full Text] [Related]
32. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients.
Koo JY; Fleischer AB; Abramovits W; Pariser DM; McCall CO; Horn TD; Gottlieb AB; Jaracz E; Rico MJ
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S195-205. PubMed ID: 16021175
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.
Hanifin JM; Paller AS; Eichenfield L; Clark RA; Korman N; Weinstein G; Caro I; Jaracz E; Rico MJ;
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S186-94. PubMed ID: 16021174
[TBL] [Abstract][Full Text] [Related]
34. Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment.
Kawashima M;
Int J Dermatol; 2006 Jun; 45(6):731-6. PubMed ID: 16796638
[TBL] [Abstract][Full Text] [Related]
35. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial.
Bensignor E; Olivry T
Vet Dermatol; 2005 Feb; 16(1):52-60. PubMed ID: 15725106
[TBL] [Abstract][Full Text] [Related]
36. Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment.
Oshio T; Sasaki Y; Funakoshi-Tago M; Aizu-Yokota E; Sonoda Y; Matsuoka H; Kasahara T
Int Immunopharmacol; 2009 Apr; 9(4):403-11. PubMed ID: 19162238
[TBL] [Abstract][Full Text] [Related]
37. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle.
Breneman D; Fleischer AB; Abramovits W; Zeichner J; Gold MH; Kirsner RS; Shull TF; Crowe AW; Jaracz E; Hanifin JM;
J Am Acad Dermatol; 2008 Jun; 58(6):990-9. PubMed ID: 18359127
[TBL] [Abstract][Full Text] [Related]
38. [Effect of topical tacrolimus ointment on expression of Toll-like receptors 2 and 4 in lesional atopic dermatitis skin].
Xie ZQ; Liu LL; Yang GY; Zhu XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):420-3. PubMed ID: 16892151
[TBL] [Abstract][Full Text] [Related]
39. Substance P restores normal skin architecture and reduces epidermal infiltration of sensory nerve fiber in TNCB-induced atopic dermatitis-like lesions in NC/Nga mice.
Choi H; Kim DJ; Nam S; Lim S; Hwang JS; Park KS; Hong HS; Won Y; Shin MK; Chung E; Son Y
J Dermatol Sci; 2018 Mar; 89(3):248-257. PubMed ID: 29269174
[TBL] [Abstract][Full Text] [Related]
40. Topical tacrolimus in the management of atopic dermatitis in Japan.
Furue M; Uchi H; Moroi Y; Ogawa S; Nakahara T; Urabe K
Dermatol Ther; 2006; 19(2):118-26. PubMed ID: 16669995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
